What is Sutro Biopharma's other working capital?

Sutro Biopharma (STRO) reported other working capital of -$109K in Q1 2026.

How has Sutro Biopharma's other working capital changed year-over-year?

Sutro Biopharma's other working capital increased by 35.1% year-over-year, from -$168K to -$109K.

What is the long-term trend for Sutro Biopharma's other working capital?

Over 3 years (2021 to 2025), Sutro Biopharma's other working capital has grown at a -22.6% compound annual growth rate (CAGR), from -$1.23M to -$571K.

What does other working capital mean?

Net change in working capital items not separately classified — a residual balancing item.

Sutro Biopharma STRO Other Working Capital

Other Working Capital at other companies

RegenxbioRGNX

-$19K-290%

XencorXNCR

$2.39M+750%

AnaptysBio, Inc.ANAB

-$8.1M+64.6%

Roivant SciencesROIV

-$8.3M-230%

Recursion Pharmaceuticals, Inc.RXRX

-$1.67M+65.3%

Tango TherapeuticsTNGX

-$21K-138%

Other financials

Income statement

See full

Revenue$14.5M-16.5%

Operating income-$29.7M+56.7%

Net income-$38.5M+49.3%

EPS (diluted)-$2.94+67.6%

Balance sheet

See full

Cash & equivalents$73.7M-30.6%

Total debt$13.6M-36.3%

Total equity-$66.9M-159%

Total assets$242.0M-24.7%

Cash flow

See full

Operating cash flow-$42.3M+37.7%

CapEx--100%

Free cash flow-$42.3M+37.8%

Valuation

See full

Market cap$489.66M+624%

Enterprise value$429.61M-2,600%

P/S4.9×+3.9×

Profitability

See full

Operating margin-120%-48.6pp

Net margin-154.2%-56.7pp

FCF margin-152.2%-51.1pp

Returns & leverage

See full

Return on equity-234.2%—

Debt / equity0.5×+0.3×

Current ratio3.1×+1.0×

Where this comes from

Reported directly by Sutro Biopharma in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sutro Biopharma's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sutro Biopharma's other working capital?: Sutro Biopharma (STRO) reported other working capital of -$109K in Q1 2026.
How has Sutro Biopharma's other working capital changed year-over-year?: Sutro Biopharma's other working capital increased by 35.1% year-over-year, from -$168K to -$109K.
What is the long-term trend for Sutro Biopharma's other working capital?: Over 3 years (2021 to 2025), Sutro Biopharma's other working capital has grown at a -22.6% compound annual growth rate (CAGR), from -$1.23M to -$571K.
What does other working capital mean?: Net change in working capital items not separately classified — a residual balancing item.